INNOVADERM CRO IS NOW INDERO.
circle

A Success Story: Pre-IND and IND Support for an Alopecia Areata Investigational Product

Indero

Indero

Team of Experts

Click here for a PDF version of this case study

Steps and Actions Taken

Pre-IND Submission

  • Clinical Section Development: Preparation of clinical sections of the pre-IND and provide clinical trial design suggestions.
  • Synopsis Writisng: Drafted the synopsis for their first clinical study.
  • Pre-Clinical Data Review: Conducted a quick review of toxicology and pre-clinical data to identify any potential impacts on the clinical phase.

IND Application

  • Respond to the FDA’s Feedback: Provide support to reply to FDA feedback received during the pre-IND.
  • Investigational Plan: Planned the clinical trials strategy to support an efficient path to drug approval.

Clinical Program Support

  • Protocol Development: Collaborated on protocol writing.

 

Key Takeaways

Comprehensive Support Client-Centric Approach Expertise in Clinical Planning
Provided clinical end-to-end support for pre-IND submission to ongoing IND application development. Demonstrated flexibility and availability to accommodate the different time zones, ensuring seamless communication and collaboration. Successfully planned and developed study synopsis, showcasing our expertise in the therapeutic area.

 

Future Considerations

Ongoing Support

Continue to provide comprehensive support as this client progresses through the clinical phases.

 

Need help with your next dermatology or rheumatology study? Tell us a little about your needs.

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Is Now

We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Additionally, our Clinical Research Unit (CRU) will keep the name Innovaderm and will continue to conduct dermatology studies.

Site Selection & Management

Our long-standing relationships with key opinion leaders and highly performing sites result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on the competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.

Hands, tablet and contact us with healthcare marketing or advertising on a website in the medical industry.

Patient Recruitment

Our dedicated patient recruitment and advertising team integrates with the study team to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology enabled recruitment service.

PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including the site selection process, budget and contract negotiations, patient engagement, and recruitment enrollment projections, all while respecting your study timelines.

PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including the site selection process, budget and contract negotiations, patient engagement, and recruitment enrollment projections, all while respecting your study timelines.